JP2016536348A5 - - Google Patents

Download PDF

Info

Publication number
JP2016536348A5
JP2016536348A5 JP2016545243A JP2016545243A JP2016536348A5 JP 2016536348 A5 JP2016536348 A5 JP 2016536348A5 JP 2016545243 A JP2016545243 A JP 2016545243A JP 2016545243 A JP2016545243 A JP 2016545243A JP 2016536348 A5 JP2016536348 A5 JP 2016536348A5
Authority
JP
Japan
Prior art keywords
pyrrol
octahydrocyclopenta
hydroxy
benzyl
rac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016545243A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016536348A (ja
JP6546596B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/057800 external-priority patent/WO2015048507A1/en
Publication of JP2016536348A publication Critical patent/JP2016536348A/ja
Publication of JP2016536348A5 publication Critical patent/JP2016536348A5/ja
Application granted granted Critical
Publication of JP6546596B2 publication Critical patent/JP6546596B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016545243A 2013-09-26 2014-09-26 Nr2bの選択的オクタヒドロ−シクロペンタ[c]ピロール負調節因子 Active JP6546596B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361883050P 2013-09-26 2013-09-26
US61/883,050 2013-09-26
PCT/US2014/057800 WO2015048507A1 (en) 2013-09-26 2014-09-26 Selective octahydro-cyclopenta[c] pyrrole negative modulators of nr2b

Publications (3)

Publication Number Publication Date
JP2016536348A JP2016536348A (ja) 2016-11-24
JP2016536348A5 true JP2016536348A5 (enExample) 2017-11-24
JP6546596B2 JP6546596B2 (ja) 2019-07-17

Family

ID=52744524

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016545243A Active JP6546596B2 (ja) 2013-09-26 2014-09-26 Nr2bの選択的オクタヒドロ−シクロペンタ[c]ピロール負調節因子

Country Status (9)

Country Link
US (4) US9540324B2 (enExample)
EP (2) EP3461827B1 (enExample)
JP (1) JP6546596B2 (enExample)
CN (1) CN105916843B (enExample)
AR (1) AR097794A1 (enExample)
ES (2) ES2910848T3 (enExample)
TW (1) TW201605791A (enExample)
UY (1) UY35750A (enExample)
WO (1) WO2015048507A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3461827B1 (en) 2013-09-26 2022-02-23 Cadent Therapeutics, Inc. Selective octahydro-cyclopenta[c]pyrrole negative modulators of nr2b
JO3579B1 (ar) * 2014-09-26 2020-07-05 Luc Therapeutics Inc مُعدِلات تفاغرية سالبة لمستقبل nr2b من المركب n-ألكيل أريل-5-أوكسي أريل-ثامن هيدرو-خماسي الحلقة [c] بيرول
EP3331886B1 (en) 2015-08-05 2020-07-15 Indivior UK Limited Dopamine d3 receptor antagonists having a bicyclo moiety
WO2018232158A1 (en) * 2017-06-15 2018-12-20 Belite Bio, Inc. Methods of treating metabolic diseases with fused bicyclic pyrroles
US11077312B2 (en) 2019-01-03 2021-08-03 Avive Solutions, Inc. Defibrillator communications architecture
WO2022118264A1 (en) * 2020-12-04 2022-06-09 Novartis Ag Dosage regimen for a nr2b-nmda receptor nam for the treatment of depression
US20240199576A1 (en) * 2021-03-26 2024-06-20 Novartis Ag Novel cyclopenta[c]pyrrol negative allosteric modulators of nr2b
BR112023018766A2 (pt) * 2021-03-26 2023-10-24 Novartis Ag Moduladores alostéricos negativos de ciclopental[c]pirrol de nr2b

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532243A (en) 1992-02-14 1996-07-02 The Dupont Merck Pharmaceutical Company Antipsychotic nitrogen-containing bicyclic compounds
US5262564A (en) 1992-10-30 1993-11-16 Octamer, Inc. Sulfinic acid adducts of organo nitroso compounds useful as retroviral inactivating agents anti-retroviral agents and anti-tumor agents
DE4341403A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
US5541217A (en) * 1995-05-17 1996-07-30 Ortho Pharmaceutical Corporation 4-arylcyclopenta[c]pyrrole analgesics
US6369076B1 (en) * 1999-10-29 2002-04-09 Merck & Co. Inc. 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists
MXPA03008109A (es) * 2001-03-07 2003-12-12 Pfizer Prod Inc Moduladores de la actividad de receptores de quimiocinas.
US7476688B2 (en) 2001-04-19 2009-01-13 Eisai R&D Management Co., Ltd. Cyclic amidine derivatives
CN1950082B (zh) 2004-03-03 2013-02-06 凯莫森特里克斯股份有限公司 双环和桥连的含氮杂环化物
US7696241B2 (en) 2004-03-04 2010-04-13 Bristol-Myers Squibb Company Bicyclic compounds as modulators of androgen receptor function and method
DK1761542T3 (da) * 2004-06-09 2008-04-28 Hoffmann La Roche Octahydropyrrolo[3,4-C] pyrrolderivater og anvendelsen deraf som antivirusmidler
JP2008507543A (ja) 2004-07-22 2008-03-13 グラクソ グループ リミテッド 抗細菌剤
WO2006113471A2 (en) 2005-04-19 2006-10-26 Merck & Co., Inc. N-alkyl-azacycloalkyl nmda/nr2b antagonists
ES2433135T3 (es) 2006-04-28 2013-12-09 Laboratorios Del Dr. Esteve, S.A. Compuestos biciclicos de tetrahidropirrol
EP1849772A1 (en) 2006-04-28 2007-10-31 Laboratorios Del Dr. Esteve, S.A. Bicyclic tetrahydropyrrole compounds
CN101230058A (zh) * 2007-01-23 2008-07-30 上海恒瑞医药有限公司 双环氮杂烷类衍生物、其制备方法及其在医药上的用途
TW200845977A (en) 2007-03-30 2008-12-01 Targacept Inc Sub-type selective azabicycloalkane derivatives
JP2011500727A (ja) 2007-10-22 2011-01-06 シェーリング コーポレイション Gpr119の活性のモジュレーターとしての二環式ヘテロ環誘導体およびその使用
US8304411B2 (en) 2008-01-23 2012-11-06 Jiangsu Hansoh Pharmaceutical Co., Ltd. Dicycloazaalkane derivates, preparation processes and medical uses thereof
US8211933B2 (en) 2008-12-12 2012-07-03 Vanderbilt University 3.3.0 bicyclic GlyT1 inhibitors and methods of making and using same
FR2945534B1 (fr) 2009-05-12 2012-11-16 Sanofi Aventis DERIVES DE CYCLOPENTAL[c]PYRROLE-2-CARBOXYLATES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2945533B1 (fr) * 2009-05-12 2011-05-27 Sanofi Aventis Derives de cyclopenta°c!pyrrolyl-alkylcarbamates d'heterocycles a 5 chainons, leur preparation et leur application en therapeutique
ES2534516T3 (es) 2010-01-07 2015-04-23 E.I. Du Pont De Nemours And Company Compuestos heterocíclicos fungicidas
US8796470B2 (en) 2010-05-25 2014-08-05 Abbvie Inc. Substituted octahydrocyclopenta[c]pyrroles as calcium channel modulators
WO2011149995A1 (en) * 2010-05-25 2011-12-01 Abbott Laboratories Novel substituted octahydrocyclopenta [c]pyrrol-4-amines as calcium channel blockers
US8501768B2 (en) 2011-05-17 2013-08-06 Hoffmann-La Roche Inc. Hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds
WO2012174199A1 (en) * 2011-06-16 2012-12-20 Merck Sharp & Dohme Corp. Imidazopyridin-2-one derivatives
WO2013013308A1 (en) * 2011-07-27 2013-01-31 Beta Pharma Canada Inc. Spirocyclic molecules as protein kinase inhibitors
JO3611B1 (ar) 2011-08-10 2020-08-27 Janssen Sciences Ireland Uc سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم
PL2796460T3 (pl) 2011-12-21 2018-12-31 Jiangsu Hengrui Medicine Co. Ltd. Sześcioczłonowa pirolowa heteroarylowa pochodna pierścieniowa, sposób jej otrzymywania i zastosowania medyczne
EP3590940B1 (en) * 2012-09-25 2021-06-09 F. Hoffmann-La Roche AG Hexahydropyrrolo[3,4-c]pyrrole derivatives and related compounds as autotaxin (atx) inhibitors and as inhibitors of the lysophosphatidic acid (lpa) production for treating e.g. renal diseases
AR095079A1 (es) * 2013-03-12 2015-09-16 Hoffmann La Roche Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
EP3461827B1 (en) 2013-09-26 2022-02-23 Cadent Therapeutics, Inc. Selective octahydro-cyclopenta[c]pyrrole negative modulators of nr2b
MA39792B1 (fr) 2014-03-26 2019-12-31 Hoffmann La Roche Composés bicycliques en tant qu'inhibiteurs de production d'autotaxine (atx) et d'acide lysophosphatidique (lpa)

Similar Documents

Publication Publication Date Title
JP3930560B2 (ja) 炎症の処置のための1,2−置換イミダゾリル化合物
RU2452738C2 (ru) Соединения, модулирующие активность c-fms и/или c-kit, и их применения
JP2019509319A5 (enExample)
JP2018535999A5 (enExample)
JP2018530591A5 (enExample)
JP2014528450A5 (enExample)
RU2010137114A (ru) Амидные производные как позитивные аллостерические модуляторы и способы их применения
CA2478156A1 (en) Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
JP2010533158A5 (enExample)
JP2011520896A5 (enExample)
JP2010508338A5 (enExample)
JP2021535134A5 (enExample)
JP2020506946A5 (enExample)
RU2018112237A (ru) Новые бициклические соединения в качестве дуальных ингибиторов atx/ca
RU2008141509A (ru) Mglur5 модуляторы 1
JP2016512515A5 (enExample)
HRP20201469T1 (hr) Derivati tetrahidroizokinolina
JP2017511378A5 (enExample)
RU2011134868A (ru) N-замещенные насыщенные гетероциклические сульфоновые соединения с активностью агонистов рецептора св2
JP2017537948A5 (enExample)
JP2005527625A5 (enExample)
RU2010125121A (ru) Биарилзамещенные производные азабициклических алканов
JP2019503385A5 (enExample)
JP2020502058A5 (enExample)
JP2019518036A5 (enExample)